Alliance Pharma agrees £350m takeover by fund manager
Updated: 2025-01-10 17:40:57
The drug manufacturer said its investors would receive 62.5 pence per share under the deal, a 40.9 per cent premium to its closing share price on Thursday.
A report by the fund manager showed that - excluding pensions - British savers hold just 8% of their wealth in equities and mutual funds.